Ads
related to: otezla starter dose instructions- SKYRIZI® Complete
Get Access To Prescription Savings
And Insurance Coverage Info.
- SKYRIZI® Results
See Results from SKYRIZI®
From Real Clinical Trial Patients.
- SKYRIZI® Resources
Skyrizi® Complete Offers Resources
To Stay On Track With Treatment.
- After SKYRIZI®
See Results From SKYRIZI®
For Real Clinical Trial Patients.
- Set Treatment Goals
Talk With Your Doctor About
Setting Goals That Work For You.
- Find a Doctor
Find A Doctor Near You
And Ask About SKYRIZI®.
- SKYRIZI® Complete
Search results
Results From The WOW.Com Content Network
Apremilast, sold under the brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. [4] The drug acts as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4). [ 4 ]
Drug titration is the process of adjusting the dose of a medication for the maximum benefit without adverse effects. [ 1 ] When a drug has a narrow therapeutic index , titration is especially important, because the range between the dose at which a drug is effective and the dose at which side effects occur is small. [ 2 ]
In pharmacokinetics, a loading dose is an initial higher dose of a drug that may be given at the beginning of a course of treatment before dropping down to a lower maintenance dose. [ 1 ] A loading dose is most useful for drugs that are eliminated from the body relatively slowly, i.e. have a long systemic half-life .
Apremilast (Otezla, Celgene) is an oral small-molecule inhibitor of the enzyme phosphodiesterase 4, which plays an important role in chronic inflammation associated with psoriasis. [ 110 ] It has been theorized that antistreptococcal medications may improve guttate and chronic plaque psoriasis; however, limited studies do not show that ...
It may also cause a temporary increase in blood pressure and decrease in heart rate after each dose, and darkening of the gums, face, and breasts. [4] The medication is a peptide and acts by activating the melanocortin receptors. [1] [5] Bremelanotide was approved for medical use in the United States in 2019.
Ads
related to: otezla starter dose instructions